NovolinR (Novo Nordisk)
Welcome to the PulseAid listing for the Novolin drug offered from Novo Nordisk. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novo Nordisk |
| NON-PROPRIETARY NAME: | Human Insulin |
| SUBSTANCE NAME: | INSULIN HUMAN |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1991-06-25 |
| END MARKETING DATE: | 0000-00-00 |
Novolin R HUMAN OTC DRUG Details:
| Item Description | Novolin R from Novo Nordisk |
| LABELER NAME: | Novo Nordisk |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([iU]/mL) |
| START MARKETING DATE: | 1991-06-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0169-1833_e7ea8689-2a6a-4b6a-8dbe-4b0acca6badc |
| PRODUCT NDC: | 0169-1833 |
| APPLICATION NUMBER: | NDA019938 |
Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers:
